XML 17 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Revenues $ 198,533 $ 190,884 $ 179,045
Cost of Sales (187,262) (179,468) (167,634)
Gross Profit 11,271 11,416 11,411
Operating Expenses      
Selling, distribution and administrative expenses (7,466) (7,276) (7,901)
Research and development (341) (392) (392)
Restructuring charges (18) (203) 0
Goodwill impairment charge (290) 0 0
Claim and litigation charges 6 0 (150)
Gain on Healthcare Technology Net Asset Exchange, net (94) 103 0
Total Operating Expenses (4,162) (7,871) (8,443)
Operating Income 7,109 3,545 2,968
Other Income, Net 90 58 63
Interest Expense (308) (353) (374)
Income from Continuing Operations Before Income Taxes 6,891 3,250 2,657
Income Tax Expense (1,614) (908) (815)
Income from Continuing Operations 5,277 2,342 1,842
Loss from Discontinued Operations, Net of Tax (124) (32) (299)
Net Income 5,153 2,310 1,543
Net Income Attributable to Noncontrolling Interests (83) (52) (67)
Net Income Attributable to McKesson Corporation $ 5,070 $ 2,258 $ 1,476
Diluted      
Continuing operations (in dollars per share) $ 23.28 $ 9.84 $ 7.54
Discontinued operations (in dollars per share) (0.55) (0.14) (1.27)
Total (in dollars per share) 22.73 9.70 6.27
Basic      
Continuing operations (in dollars per share) 23.50 9.96 7.66
Discontinued operations (in dollars per share) (0.55) (0.14) (1.29)
Total (in dollars per share) $ 22.95 $ 9.82 $ 6.37
Weighted Average Common Shares      
Diluted (in shares) 223 233 235
Basic (in shares) 221 230 232
Healthcare Technology Net Asset Exchange      
Operating Expenses      
Gain on Healthcare Technology Net Asset Exchange, net $ 3,947 $ 0 $ 0